Navigation Links
Mr. Ronald L. Chez Filed Amended 13D for RepliGen Corporation
Date:6/22/2011

CHICAGO, June 22, 2011 /PRNewswire/ -- Amended 13D for RepliGen Corporation was filed with the SEC by Mr. Ronald L. Chez, a private investor.

Mr. Ronald L. Chez is the President of Ronald L. Chez, Inc., and a private investor.

RepliGen Corporation is a biopharmaceutical company focused on building an integrated company by developing and marketing innovative drugs that deliver the benefits of protein therapies in the fields of neurology and gastroenterology.  RepliGen has a core competency in the development and manufacturing of biologics products, which is the basis for its bioprocessing business and RepliGen has out-licensed certain biologics intellectual property, which provide ongoing sources of revenue. Corporate headquarters are located at 41 Seyon Street, Waltham, Massachusetts 02453.

Inquiry Contact:
Barry Fischer
(312) 580-2233


'/>"/>
SOURCE Ronald L. Chez
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors
2. Keppra XR(TM) Extended-Release Tablets Filed with the FDA
3. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
4. Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
5. Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
6. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
7. Shareholder Class Action Filed Against SciClone Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
8. Class Action Lawsuit Filed Against DePuy Orthopaedics, Inc.
9. DePuy Recalled Hip Device Lawsuit Filed in East Texas
10. DePuy Recalled Hip Device Lawsuit Filed in San Antonio, Texas
11. DePuy Recalled Hip Device Lawsuit Filed in Austin, Texas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), a ... Urology, Uro/Gyn and Gynecology markets with innovative and ... joined the Company as Senior Vice President, Marketing ... Mr. Keswani will report directly to Darin ... organization is delighted that Ash has joined the ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology:
(Date:4/24/2017)... McLean, Virginia (PRWEB) , ... April 24, 2017 ... ... have announced that they are seeking public support to bring their novel lifesaving ... in appearance, wearable device packed with medical-grade sensors, specially designed to read a ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... telehealth industry, announces the company’s VideoMedicine mobile platform has launched Quick Care, a ... hours a day, Quick Care provides patients with the option to request and ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... opioid overdose deaths now claim the lives of 62 Americans each day.(1) Yet ... against drug manufacturers, distributors, pharmacies and prescribers by more than half.(2) Novus ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... recognize elevated anxiety levels in people with addiction who are served by MAP’s ... a biosensing wearable device that monitors heart and breath rates to identify anxiety ...
(Date:4/24/2017)... Boston, MA (PRWEB) , ... April 24, 2017 ... ... the cardiovascular health of individuals with HIV because it is not known to ... statins may have favorable effects to both lower cholesterol levels and dampen inflammation ...
Breaking Medicine News(10 mins):